Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with alopecia areata in Syria are young adult males, often with patchy scalp hair loss.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Men with alopecia areata have different body fat distribution compared to healthy men.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Activating Tgr5 may help treat hair loss and bone loss.

A new method improves alopecia diagnosis using non-invasive steps.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.